TNXP - Spark Newswire

2 minute read

News

Tonix Pharmaceuticals Announces Publication Of Paper On Antiviral SARS-CoV-2 Inhibitor, TNX-3500, In JCI Insight

November 22, 5:09 PM

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced the publication of "Sangivamycin is highly effective against SARS-CoV-2 in vitro

TNXP

6 minute read

The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data

By Shanthi Rexaline

November 9, 9:13 AM

Here's a roundup of top developments in the biotech space over the last 24 hours:

ACHV

2 minute read

Tonix Pharma Highlights Presentation of Phase 3 RELIEF Study Of TNX-102 SL For Mgmt. Of Fibromyalgia At American College Of Rheumatology Convergence

By Benzinga Newsdesk

November 8, 5:27 PM

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced an oral presentation of positive results from its Phase 3 clinical study, RELIEF, of

TNXP

1 minute read

Tonix Pharmaceuticals Q3 EPS $(0.05) Up From $(0.09) YoY

By Benzinga Newsdesk

November 8, 8:17 AM

Tonix Pharmaceuticals (NASDAQ:TNXP) reported quarterly losses of $(0.05) per share. This is a 44.44 percent increase over losses of $(0.09) per share from the same period last year.

TNXP

1 minute read

Tonix Tweets ‘Tonix Pharmaceuticals CMO Dr. Gregory Sullivan will present results from the RELIEF study at this year’s @ACRheum Convergence 2021. This positive Phase 3 study investigated the use of TNX-102 SL for the management of #fibromyalgia.’

By Benzinga Newsdesk

November 3, 1:37 PM

https://twitter.com/TonixPharma/status/1455951642197647364

TNXP

7 minute read

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline

By Shanthi Rexaline

October 31, 2:23 PM

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected.

ADPT

4 minute read

For COVID-19, Live Virus Vaccines Could Give Longer Term Protection Than the Current Warp Speed Vaccines — But They’re Not Here Yet

September 14, 8:16 AM

Photo by Diana Polekhina on Unsplash

TNXP

1 minute read

Tonix Pharma Shares FDA Response For COVID-19 Vaccine Candidate Human Study

By Vandana Singh

September 13, 9:44 AM

Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) announced that it received the official written response from a Type B pre-Investigational New Drug (IND)…

TNXP

4 minute read

Tonix Pharmaceuticals Announces Results Of Pre-IND Meeting With FDA For TNX-1800 As A Potential Vaccine To Prevent COVID-19; Says Phase 1 Trial Expected To Start In 1H Of 2022

By Bill Haddad

September 13, 8:02 AM

TNX-1800 is a Live Virus Vaccine Designed to Elicit Durable T cell Immunity TNX-1800 is a Modified Version of Dr. Edward Jenner's Vaccine that Eradicated Smallpox, Engineered to Express SARS-CoV-2 Spike

TNXP

1 minute read

12 Health Care Stocks Moving In Tuesday’s Pre-Market Session

By Benzinga Insights

August 24, 8:11 AM

BPTH

Feed Symbols: TNXP